Pathophysiology of spastic paresis. The hypothesis of «incomplete movement»
A. P. Kovalenko
Bulletin of the Russian Military Medical Academy ›› 2019, Vol. 21 ›› Issue (4) : 235 -239.
Pathophysiology of spastic paresis. The hypothesis of «incomplete movement»
The structural analysis of modern views on the physiology of spasticity is presented. Based on the well-known provisions on the physiology of movement and the pathophysiology of damage to the upper (first, central) motor neurons, a hypothesis is developed for the development of spasticity as an «incomplete movement», its individual provisions are formulated. In the context of the stated hypothesis, explanations are given to some clinical phenomena and the definition of spasticity is formulated. An explanation of the variability of the patterns of spasticity is proposed both within the framework of one pathology and with various nosological forms. The main strategies in the treatment and rehabilitation of the syndrome of damage to the upper motor neurons are formulated and their physiological justification is given. From a new point of view, the effectiveness of some rehabilitation techniques (therapeutic styling, taping, early use of physiotherapy exercises, creating a comfortable environment, etc.) has been comprehended. Particular attention is paid to the effects of the administration and pharmacodynamics of type A botulinum neurotoxin preparations. A pathophysiological rationale for the reciprocating positive dynamics in the treatment of spasticity with botulinum toxin drugs is proposed as part of the overall rehabilitation process, which gives grounds to consider botulinum neurotoxin injections as an essential element of rehabilitation programs. The proposed hypothesis of «incomplete movement» allows to take a fresh look at the pathophysiology of spasticity, its clinical manifestations and answer many questions. Nevertheless, it requires critical consideration and the formation of an evidence base to confirm the hypothesis.
spasticity / pathophysiology of central paresis / upper motor neuron injury syndrome / spasticity patterns / rehabilitation / botulinum neurotoxin / hypothesis of spasticity formation
| [1] |
Бернштейн Н.А. Очерки по физиологии движений и физиологии активности / Н.А. Бернштейн. – М.: Наука, 1990. – 496 с. |
| [2] |
Гранит, Р. Основы регуляции движений: пер. с англ. / Р. Гранит; под ред. В.С. Гурфинкеля. – М.: Мир, 1973. – 368 с. |
| [3] |
Искра, Д.А. Спастичность: от патофизиологии к лечению / Д.А.Искра [и др.] // Журн. неврологии и психиатрии им. С.С. Корсакова. – 2018. – № 118 (10). – С. 108–114. |
| [4] |
Николаев, С.Г. Электромиография: клинический практикум / С.Г. Николаев. – Иваново: ПресСто, 2013. – 394 с. |
| [5] |
Орлова, О.Р. Возможности и перспективы использования ботулотоксина в клинической практике / О.Р. Орлова // Росс. мед. журн. – 2006. – С. 23. |
| [6] |
Хатькова, С.Е. Ботулинотерапия в лечении спастичности нижней конечности / С.Е. Хатькова [и др.] // Нервно- мышечные болезни. – 2017. – № 7. – С. 27–35. |
| [7] |
Banky, M. Do clinical tests of spasticity accurately reflect muscle function during walking: a systematic review / M. Banky [et al.] // Brain Inj. – 2017. № 31 (4): – P. 440–455. |
| [8] |
Beazley, W.C. Results of nerve grafting in severe soft tissue injuries/ W.C. Beazley, M.A. Milek, B.H. Reiss // Clin. orthop. relat. res. – 1984. – № 188. – P. 208–212. |
| [9] |
Caty, G.D. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. / G.D. Caty [et al.] // Stroke. – 2008. – № 39 (10). – P.2803–2808. |
| [10] |
Bryan, D.J. Enhanced peripheral nerve regeneration through a poled bioresorbable poly (lactic-coglycolic acid) guidance channel / D.J. Bryan [et al.] // J. neural. Eng. – 2004. – №1. – P. 91–98. |
| [11] |
Ciardelli, G. Materials for peripheral nerve regeneration / G. Ciardelli, V. Chiono // Macromol. biosci. – 2006. – № 6. – P.13–26. |
| [12] |
Dolly, J.O. Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics / J.O. Dolly [et al.] // Curr Opin Pharmacol. – 2009. – № 9. – P. 326–335. |
| [13] |
European consensus table on the use of botulinum toxin type A in adult spasticity // Article (PDF Available) in Journal of rehabilitation medicine: official journal of the UEMS European Board of Physical and Rehabilitation Medicine. – № 41 (1). – P. 13–25. |
| [14] |
Evans, G.R. Approaches to tissue engineered peripheral nerve / G.R. Evans // Clin. plastic. surg. – 2003. – № 30. – P. 559–563. |
| [15] |
Fu, S.Y. The cellular and molecular basis of peripheral nerve regeneration / S.Y. Fu, T. Gordon // Mol. neurobiol. – 1997. – №14. – P. 67–116. |
| [16] |
Heine, W. Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves / W. Heine [et al.] // Exp. neurol. – 2004. – № 189. – P. 231–240. |
| [17] |
Gracies, J.M. International AbobotulinumtoxinA Adult Lower Limb Spasticity Study Group. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension / J.M. Gracies [et al.] // Neurology. – 2017. – № 89 (22). – P. 2245–2253. |
| [18] |
Maynard, F. Epidemiology of spasticity following traumatic spinal cord injury / F. Maynard, R. Karunas, W. Waring // Arch Phys Med Rehabil. – 1990. – № 71 (8): – Р. 566–569. |
| [19] |
Milanov, I.G. Examination of the segmental pathophysiological mechanisms of spasticity / I.G. Milanov // Electromyogr. Clin. Neurophisiol. – 1994. – № 34. – Р. 73–79. |
| [20] |
Murakami, T. Transplanted neuronal progenitor cells in a peripheral nerve gap promote nerve repair / T. Murakami [et al.] // Brain res. – 2003. – № 974. – P. 17–24. |
| [21] |
Otto, D. Pharmacological effects of nerve growth factor and fibroblast growth factor applied to the transectioned sciatic nerve on neuron death in adult dorsal root ganglia / D. Otto, K. Unsicker, С. Grothe // Neurosci. lett. – 1987. – № 83. – P. 156–160. |
| [22] |
Tohill, M. Stem cell plasticity and therapy for injuries of the peripheral nervous system / M. Tohill, G. Terenghi // Biotechnol. appl. biochem. – 2004. – № 40. – P. 17–24. |
| [23] |
Upper Motor Neurone Syndrome and Spasticity: Clinical Management and Neurophisiology / Edd. by Michael P. Barnes, Garth R. Johnson. – Cambridge University Press. New York, 2008. – 250 р. |
| [24] |
Zorowitz, R. Poststroke spasticity: sequelae and burden on stroke survivors and caregivers / R. Zorowitz, P. Gillard, M. Brainin // Neurology. – 2013. – № 80. – P. 45–52. |
Eco-Vector
/
| 〈 |
|
〉 |